Clinical Characteristics of the Responders to Dipeptidyl Peptidase-4 Inhibitors in Korean Subjects with Type 2 Diabetes

We investigated characteristics associated with the efficacy of dipeptidyl peptidase-4 inhibitors (DPP4i) in Korean patients with type 2 diabetes. We reviewed medical records of 477 patients who had taken sitagliptin or vildagliptin longer than 40 weeks. Response to DPP4i was evaluated with HbA1c ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Tae Jung, Jung, Hye Seung, Bae, Jae Hyun, Kim, Yeong Gi, Park, Kyeong Seon, Cho, Young Min, Park, Kyong Soo, Kim, Seong Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678005/
https://www.ncbi.nlm.nih.gov/pubmed/23772153
http://dx.doi.org/10.3346/jkms.2013.28.6.881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678005/
https://www.ncbi.nlm.nih.gov/pubmed/23772153
http://dx.doi.org/10.3346/jkms.2013.28.6.881

Ejemplares similares